Our Career Development Faculty is made up of scientists who have excelled as postdocs, have a very strong publishing and funding record, and are beginning to pursue independent research programmes.
The Career Development Faculty is the route generally taken for new leaders in areas in which the ICR is making significant investment, identified by our leadership as needing expansion in order to meet the aims of our research strategy.
Often these are in cutting-edge areas of cancer research, such as immunotherapy, or disciplines from outside ‘traditional’ biological sciences. Many members of our Career Development Faculty are strong team scientists, bringing fresh expertise in innovative areas.
Joining as a Team Leader, you will be given outstanding support to help you to continue to develop in your career. You’ll receive a competitive start-up package of funding, as well as the guidance you need to start up your first lab – from lab space and equipment, to help recruiting postdoctoral students, technicians and PhD students.
You’ll have the space to grow, excel and make your mark while gaining dedicated support with grant applications, leadership training.
At the Institute of Cancer Research, London, we support our scientists with state-of-the-art platform technologies and expert facilities staff. We provide cutting-edge facilities for microscopy, imaging, sequencing, proteomics, X-ray crystallography and much more.
Find out more
Dr Andrea Sottoriva
Team Leader, Evolutionary Genomics and Modelling
As an expert in bioinformatics – having spent his early career in astrophysics – Dr Andrea Sottoriva is breaking new ground in applying mathematics and evolutionary science to cancer. His team is applying skills in computer science and mathematics to big datasets, seeking out the evolutionary patterns that guide cancer’s development.
Dr Sottoriva was part of our Career Development Faculty before recently being given a non-time limited appointment and joining our permanent Faculty.
“The ICR has a collaborative and dynamic environment that was very open minded to my multidisciplinary approach to cancer research. It really struck me how at the ICR, scientists and clinicians from different disciplines could sit together to tackle the challenges we have in cancer medicine, each one providing a different and unique angle to the problem.”